Normal blood clotting values in premature babies
Part of Women’s health & pregnancy clinical trials.
This trial measures normal blood clotting (hemostasis) in infants up to 18 months old, especially premature babies. It helps doctors understand typical clotting levels to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 18 months old or younger
- A blood sample was sent to the hospital lab to check a clotting-related value
- Your baby doesn’t have a known bleeding disorder (like hemophilia or von Willebrand disease)
- Your baby doesn’t have severe liver problems
- All required medical records are complete
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
This study is testing a new device, called Quantra, that checks how well your child's blood clots during surgery. By comparing its results to standard lab tests in healthy children, researchers hope to confirm it is accurate and useful for guiding treatment in kids.
This study aims to see if a scoring system can help predict the outcome for newborns with DIC, a condition where blood clotting is abnormal. It may help doctors better understand and manage this condition.
Hear when a new Premature Infant, Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.